Terms: = Prostate cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Diagnosis
721 results:
1. [Application of 1470 nm semiconductor laser in the treatment of benign prostatic hyperplasia in ultra-aged patients].
Wu D; Yi XM; Wei HX; Zhang KX; Shi CJ; Shi XQ; Xu ZY; Fu D
Zhonghua Nan Ke Xue; 2023 Sep; 29(9):831-836. PubMed ID: 38639597
[TBL] [Abstract] [Full Text] [Related]
2. Compliance With NCCN Guidelines for Evaluation and Treatment of Anemia Among Patients With Solid Tumors.
Hufnagel DH; Bos LM; Brown AJ; Prescott LS
J Natl Compr Canc Netw; 2024 Mar; 22(3):. PubMed ID: 38489926
[TBL] [Abstract] [Full Text] [Related]
3. Concurrent Tissue and Circulating Tumor DNA Molecular Profiling to Detect Guideline-Based Targeted Mutations in a Multicancer Cohort.
Iams WT; Mackay M; Ben-Shachar R; Drews J; Manghnani K; Hockenberry AJ; Cristofanilli M; Nimeiri H; Guinney J; Benson AB
JAMA Netw Open; 2024 Jan; 7(1):e2351700. PubMed ID: 38252441
[TBL] [Abstract] [Full Text] [Related]
4. Treatment Patterns of Bone-targeting Agents Among Solid Tumor Patients With Bone Metastases: An Analysis of Electronic Health Record Data in the United States From 2014 to 2018.
Nicholson G; Carlson KB; Hernandez RK; Schenfeld J; Cadieux B; Henry D; De Sousa Barbosa VJ; Saad H
Am J Clin Oncol; 2024 Apr; 47(4):177-184. PubMed ID: 38200688
[TBL] [Abstract] [Full Text] [Related]
5. Phase I/IIa trial of 18F-prostate specific membrane antigen (PSMA) 1007 PET/CT in healthy volunteers and prostate cancer patients.
Tateishi U; Kimura K; Tsuchiya J; Kano D; Watabe T; Nonomura N; Saito K; Yokoyama K; Yamagiwa K; Adachi T; Kojima Y; Yoshida S; Fujii Y
Jpn J Clin Oncol; 2024 Mar; 54(3):282-291. PubMed ID: 38066703
[TBL] [Abstract] [Full Text] [Related]
6. Preference Elicitation and Treatment Decision-Making Among Men Diagnosed With prostate cancer: Randomized Controlled Trial Results of Healium.
Diefenbach MA; Marziliano A; Tagai EK; Pfister H; Lapitan E; Hall SJ; Vira M; Ibrahim S; Aibel K; Kutikov A; Horwitz EM; Miyamoto C; Reese AC; Miller SM
J Med Internet Res; 2023 Oct; 25():e46552. PubMed ID: 37862103
[TBL] [Abstract] [Full Text] [Related]
7. SLCO1B3 and SLCO2B1 genotypes, androgen deprivation therapy, and prostate cancer outcomes: a prospective cohort study and meta-analysis.
Rajanala SH; Plym A; Vaselkiv JB; Ebot EM; Matsoukas K; Lin Z; Chakraborty G; Markt SC; Penney KL; Lee GM; Mucci LA; Kantoff PW; Stopsack KH
Carcinogenesis; 2024 Feb; 45(1-2):35-44. PubMed ID: 37856781
[TBL] [Abstract] [Full Text] [Related]
8. Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study.
Callender T; Imrie F; Cebere B; Pashayan N; Navani N; van der Schaar M; Janes SM
PLoS Med; 2023 Oct; 20(10):e1004287. PubMed ID: 37788223
[TBL] [Abstract] [Full Text] [Related]
9. Conditional Risks of Biochemical Failure and prostate cancer-Specific Death in Patients Undergoing External Beam Radiotherapy: A Secondary Analysis of 2 Randomized Clinical Trials.
Alexander GS; Krc RF; Assif JW; Sun K; Molitoris JK; Tran P; Rana Z; Bentzen SM; Mishra MV
JAMA Netw Open; 2023 Sep; 6(9):e2335069. PubMed ID: 37751207
[TBL] [Abstract] [Full Text] [Related]
10. Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive prostate cancer.
Darst BF; Saunders E; Dadaev T; Sheng X; Wan P; Pooler L; Xia LY; Chanock S; Berndt SI; Wang Y; Patel AV; Albanes D; Weinstein SJ; Gnanapragasam V; Huff C; Couch FJ; Wolk A; Giles GG; Nguyen-Dumont T; Milne RL; Pomerantz MM; Schmidt JA; Travis RC; Key TJ; Stopsack KH; Mucci LA; Catalona WJ; Marosy B; Hetrick KN; Doheny KF; MacInnis RJ; Southey MC; Eeles RA; Wiklund F; Conti DV; Kote-Jarai Z; Haiman CA
JAMA Oncol; 2023 Nov; 9(11):1514-1524. PubMed ID: 37733366
[TBL] [Abstract] [Full Text] [Related]
11. A blood-based metabolomic signature predictive of risk for pancreatic cancer.
Irajizad E; Kenney A; Tang T; Vykoukal J; Wu R; Murage E; Dennison JB; Sans M; Long JP; Loftus M; Chabot JA; Kluger MD; Kastrinos F; Brais L; Babic A; Jajoo K; Lee LS; Clancy TE; Ng K; Bullock A; Genkinger JM; Maitra A; Do KA; Yu B; Wolpin BM; Hanash S; Fahrmann JF
Cell Rep Med; 2023 Sep; 4(9):101194. PubMed ID: 37729870
[TBL] [Abstract] [Full Text] [Related]
12. Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant prostate cancer.
Hwang C; Henderson NC; Chu SC; Holland B; Cackowski FC; Pilling A; Jang A; Rothstein S; Labriola M; Park JJ; Ghose A; Bilen MA; Mustafa S; Kilari D; Pierro MJ; Thapa B; Tripathi A; Garje R; Ravindra A; Koshkin VS; Hernandez E; Schweizer MT; Armstrong AJ; McKay RR; Dorff TB; Alva AS; Barata PC
JAMA Netw Open; 2023 Sep; 6(9):e2334208. PubMed ID: 37721753
[TBL] [Abstract] [Full Text] [Related]
13. Regional differences in penile cancer patient characteristics and treatment rates across the United States.
Scheipner L; Cano Garcia C; Barletta F; Incesu RB; Morra S; Baudo A; Assad A; Tian Z; Saad F; Shariat SF; Chun FKH; Briganti A; Tilki D; Longo N; Carmignani L; Leitsmann M; Ahyai S; Karakiewicz PI
Cancer Epidemiol; 2023 Oct; 86():102424. PubMed ID: 37506474
[TBL] [Abstract] [Full Text] [Related]
14. Determining the association of rurality and cardiovascular disease among prostate cancer survivors.
Nielsen S; O'Neil B; Chang CP; Mark B; Snyder J; Deshmukh V; Newman M; Date A; Galvao C; Henry NL; Lloyd S; Hashibe M
Urol Oncol; 2023 Oct; 41(10):429.e15-429.e23. PubMed ID: 37455231
[TBL] [Abstract] [Full Text] [Related]
15. Training Community African American and Hispanic/Latino/a Advocates on prostate cancer (PCa): a Multicultural and Bicoastal Approach.
Aristizabal C; Suther S; Yao Y; Behar-Horenstein LS; Webb F; Stern MC; Baezconde-Garbanati L
J Cancer Educ; 2023 Oct; 38(5):1719-1727. PubMed ID: 37452225
[TBL] [Abstract] [Full Text] [Related]
16. Quality of life in the year after new diagnosis with advanced prostate cancer for Black and White individuals living in the US.
Rencsok EM; Slopen N; Autio K; Morgans A; McSwain L; Barata P; Cheng HH; Dreicer R; Heath E; McKay RR; Pomerantz M; Rathkopf D; Tagawa S; Whang YE; Ragin C; Odedina FT; George DJ; Kantoff PW; Vinson J; Villanti P; Haneuse S; Mucci LA;
Qual Life Res; 2023 Nov; 32(11):3209-3221. PubMed ID: 37410340
[TBL] [Abstract] [Full Text] [Related]
17. Point-of-care diagnostics for rapid determination of prostate cancer biomarker sarcosine: application of disposable potentiometric sensor based on oxide-conductive polymer nanocomposite.
Yamani HZ; Safwat N; Mahmoud AM; Ayad MF; Abdel-Ghany MF; Gomaa MM
Anal Bioanal Chem; 2023 Sep; 415(22):5451-5462. PubMed ID: 37389600
[TBL] [Abstract] [Full Text] [Related]
18. Serum Essential Elements and Survival after cancer diagnosis.
Lubiński J; Lener MR; Marciniak W; Pietrzak S; Derkacz R; Cybulski C; Gronwald J; Dębniak T; Jakubowska A; Huzarski T; Matuszczak M; Pullella K; Sun P; Narod SA
Nutrients; 2023 Jun; 15(11):. PubMed ID: 37299574
[TBL] [Abstract] [Full Text] [Related]
19. Diabetes and prostate cancer Outcomes in Men with Nonmetastatic Castration-Resistant prostate cancer: Results from the SEARCH Cohort.
Sergeyev A; Gu L; De Hoedt AM; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Klaassen Z; Terris MK; Guerrios-Rivera L; Freedland SJ; Csizmadi I
Cancer Epidemiol Biomarkers Prev; 2023 Sep; 32(9):1208-1216. PubMed ID: 37294698
[TBL] [Abstract] [Full Text] [Related]
20. Comparing Risk for Second Primary cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for prostate cancer, 2002-2015.
Pithadia KJ; Advani PG; Citrin DE; Bekelman JE; Withrow DR; Berrington de Gonzalez A; Morton LM; Schonfeld SJ
JAMA Oncol; 2023 Aug; 9(8):1119-1123. PubMed ID: 37289449
[TBL] [Abstract] [Full Text] [Related]
[Next]
